Literature DB >> 19617690

Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1.

A C V Krepischi-Santos1, D Rajan, I K Temple, V Shrubb, J A Crolla, S Huang, S Beal, P A Otto, N P Carter, A M Vianna-Morgante, C Rosenberg.   

Abstract

Chromosome microdeletions or duplications are detected in 10-20% of patients with mental impairment and normal karyotypes. A few cases have been reported of mental impairment with microdeletions comprising tumor suppressor genes. By array-CGH we detected 4 mentally impaired individuals carrying de novo microdeletions sharing an overlapping segment of approximately 180 kb in 17p13.1. This segment encompasses 18 genes, including 3 involved in cancer, namely KCTD11/REN, DLG4/PSD95, and GPS2. Furthermore, in 2 of the patients, the deletions also included TP53, the most frequently inactivated gene in human cancers. The 3 tumor suppressor genes KCTD11, DLG4, and GPS2, in addition to the GABARAP gene, have a known or suspected function in neuronal development and are candidates for causing mental impairment in our patients. Among our 4 patients with deletions in 17p13.1, 3 were part of a Brazilian cohort of 300 mentally retarded individuals, suggesting that this segment may be particularly prone to rearrangements and appears to be an important cause (approximately 1%) of mental retardation. Further, the constitutive deletion of tumor suppressor genes in these patients, particularly TP53, probably confers a significantly increased lifetime risk for cancer and warrants careful oncological surveillance of these patients. Constitutional chromosome deletions containing tumor suppressor genes in patients with mental impairment or congenital abnormalities may represent an important mechanism linking abnormal phenotypes with increased risks of cancer. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617690      PMCID: PMC2813804          DOI: 10.1159/000218743

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  21 in total

Review 1.  The role of p53 in human cancer.

Authors:  D Malkin
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

Review 2.  Suppressors of hedgehog signaling: Linking aberrant development of neural progenitors and tumorigenesis.

Authors:  Lucia Di Marcotullio; Elisabetta Ferretti; Enrico De Smaele; Isabella Screpanti; Alberto Gulino
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

3.  Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents.

Authors:  C Rosenberg; J Knijnenburg; E Bakker; A M Vianna-Morgante; W Sloos; P A Otto; M Kriek; K Hansson; A C V Krepischi-Santos; H Fiegler; N P Carter; E K Bijlsma; A van Haeringen; K Szuhai; H J Tanke
Journal:  J Med Genet       Date:  2005-06-24       Impact factor: 6.318

4.  Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden.

Authors:  Tone Bjørge; Sven Cnattingius; Rolv Terje Lie; Steinar Tretli; Anders Engeland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02-22       Impact factor: 4.254

5.  G-protein pathway suppressor 2 (GPS2) interacts with the regulatory factor X4 variant 3 (RFX4_v3) and functions as a transcriptional co-activator.

Authors:  Donghui Zhang; G Jean Harry; Perry J Blackshear; Darryl C Zeldin
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

Review 6.  Chromosome 17p deletion in human medulloblastoma: a missing checkpoint in the Hedgehog pathway.

Authors:  Enrico De Smaele; Lucia Di Marcotullio; Elisabetta Ferretti; Isabella Screpanti; Edoardo Alesse; Alberto Gulino
Journal:  Cell Cycle       Date:  2004-10-03       Impact factor: 4.534

7.  Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Authors:  Magali Olivier; David E Goldgar; Nayanta Sodha; Hiroko Ohgaki; Paul Kleihues; Pierre Hainaut; Rosalind A Eeles
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

Review 8.  Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm.

Authors:  Elisabetta Ferretti; Enrico De Smaele; Lucia Di Marcotullio; Isabella Screpanti; Alberto Gulino
Journal:  Trends Mol Med       Date:  2005-11-14       Impact factor: 11.951

9.  REN: a novel, developmentally regulated gene that promotes neural cell differentiation.

Authors:  Rita Gallo; Francesca Zazzeroni; Edoardo Alesse; Claudia Mincione; Ugo Borello; Pasquale Buanne; Roberta D'Eugenio; Andrew R Mackay; Beatrice Argenti; Roberto Gradini; Matteo A Russo; Marella Maroder; Giulio Cossu; Luigi Frati; Isabella Screpanti; Alberto Gulino
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

10.  Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication.

Authors:  Blake C Ballif; Aaron Theisen; Justine Coppinger; Gordon C Gowans; Joseph H Hersh; Suneeta Madan-Khetarpal; Karen R Schmidt; Raymond Tervo; Luis F Escobar; Christopher A Friedrich; Marie McDonald; Lindsey Campbell; Jeffrey E Ming; Elaine H Zackai; Bassem A Bejjani; Lisa G Shaffer
Journal:  Mol Cytogenet       Date:  2008-04-28       Impact factor: 2.009

View more
  10 in total

1.  A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes.

Authors:  Adam Shlien; Berivan Baskin; Maria Isabel W Achatz; Dimitrios J Stavropoulos; Kim E Nichols; Louanne Hudgins; Chantal F Morel; Margaret P Adam; Nataliya Zhukova; Lianne Rotin; Ana Novokmet; Harriet Druker; Mary Shago; Peter N Ray; Pierre Hainaut; David Malkin
Journal:  Am J Hum Genet       Date:  2010-11-12       Impact factor: 11.025

2.  Haploinsufficiency of ANKRD11 causes mild cognitive impairment, short stature and minor dysmorphisms.

Authors:  Mala Isrie; Yvonne Hendriks; Nicole Gielissen; Erik A Sistermans; Marjolein H Willemsen; Hilde Peeters; Joris R Vermeesch; Tjitske Kleefstra; Hilde Van Esch
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

3.  Dosage changes of a segment at 17p13.1 lead to intellectual disability and microcephaly as a result of complex genetic interaction of multiple genes.

Authors:  Claudia M B Carvalho; Shivakumar Vasanth; Marwan Shinawi; Chad Russell; Melissa B Ramocki; Chester W Brown; Jesper Graakjaer; Anne-Bine Skytte; Angela M Vianna-Morgante; Ana C V Krepischi; Gayle S Patel; LaDonna Immken; Kyrieckos Aleck; Cynthia Lim; Sau Wai Cheung; Carla Rosenberg; Nicholas Katsanis; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-11-06       Impact factor: 11.025

4.  Intellectual disability, oncogenes and tumour suppressor genes: the way forward?

Authors:  M Bidart; C Coutton
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

5.  Endocrinological Abnormalities Are a Main Feature of 17p13.1 Microduplication Syndrome: A New Case and Literature Review.

Authors:  Ilenia Maini; Ivan Ivanovski; Alessandro Iodice; Simonetta Rosato; Marzia Pollazzon; Manuela Mussini; Elga F Belligni; Charles Coutton; Maria Marinelli; Veronica Barbieri; Manuela Napoli; Rosario Pascarella; Chiara Sartori; Francesca Madia; Carlo Fusco; Fabrizia Franchi; Maria E Street; Livia Garavelli
Journal:  Mol Syndromol       Date:  2016-10-14

6.  Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression.

Authors:  Roman Tremmel; Kathrin Klein; Florian Battke; Sarah Fehr; Stefan Winter; Tim Scheurenbrand; Elke Schaeffeler; Saskia Biskup; Matthias Schwab; Ulrich M Zanger
Journal:  Hum Genet       Date:  2019-11-30       Impact factor: 4.132

7.  Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder.

Authors:  Christopher S Poultney; Arthur P Goldberg; Elodie Drapeau; Yan Kou; Hala Harony-Nicolas; Yuji Kajiwara; Silvia De Rubeis; Simon Durand; Christine Stevens; Karola Rehnström; Aarno Palotie; Mark J Daly; Avi Ma'ayan; Menachem Fromer; Joseph D Buxbaum
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

8.  Aberrant upregulation of LRRC1 contributes to human hepatocellular carcinoma.

Authors:  Yandong Li; Bo Zhou; Jihong Dai; Ruifang Liu; Ze-Guang Han
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

9.  Germline DNA copy number variation in familial and early-onset breast cancer.

Authors:  Ana Cv Krepischi; Maria Isabel W Achatz; Erika Mm Santos; Silvia S Costa; Bianca Cg Lisboa; Helena Brentani; Tiago M Santos; Amanda Gonçalves; Amanda F Nóbrega; Peter L Pearson; Angela M Vianna-Morgante; Dirce M Carraro; Ricardo R Brentani; Carla Rosenberg
Journal:  Breast Cancer Res       Date:  2012-02-07       Impact factor: 6.466

10.  Rare de novo copy number variants in patients with congenital pulmonary atresia.

Authors:  Li Xie; Jin-Lan Chen; Wei-Zhi Zhang; Shou-Zheng Wang; Tian-Li Zhao; Can Huang; Jian Wang; Jin-Fu Yang; Yi-Feng Yang; Zhi-Ping Tan
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.